This publication, with contributions from over 30 experts, aims to provide a comprehensive, well-referenced blueprint to guide researchers, clinicians, industry partners, academics, and TB controllers in all sectors in all aspects of TB diagnostics development, from concept to evaluation, implementation, scale-up, delivery and impact.
This booklet calls upon national programs for TB control, donors, financing institutions, civil society, media, and communities to join hands in intensifying the fight against drug-resistant TB.
The purpose of the Menu is to provide a set of optional provisions for consideration by public health officials and their legal counsel in their efforts to eliminate tuberculosis.
The Global Drug Facility (GDF) is a mechanism to expand access to, and availability of, high-quality anti-TB drugs and diagnostics to support the Stop TB Strategy.
This document outlines progress that GDF has made to date, what still needs to be done and where high-level advocacy could help GDF to further scale up its activities.
This pamphlet provides general information about LTBI and TB disease diagnosis and treatment as well as information about home isolation.
This fact sheet introduces the TB blood test, also called an Interferon Gamma Release Assay or IGRA.
This brochure was developed for clinicians to use with patients while discussing the 12-dose regimen. The brochure contains information on latent TB infection, the 12-dose regimen, treatment schedules, and adverse events. There is space on this brochure to write in treatment schedules and clinic/office contact information.
World TB Day poster available in 5 languages: Creole, English, French, Portuguese, and Spanish
This brochure provides basic information for patients about the TB blood test.
This slide set provides a summary of TB cases in a correctional facility at the time of diagnosis for the years 1993 through 2011.
